Search
Searching Content indexed under Healthcare by Hogan Lovells ordered by Published Date Descending.
Links to Result pages
 
1 2 3  
>>Next
 
Title
Country
Organisation
Author
Date
1
Online Sale Of Pharmaceuticals In Russia Remains Prohibited And Lawmakers Are Yet To Pass The Bill Allowing Online Sales
Russian law currently prohibits the online sale of pharmaceuticals and requires that pharmaceuticals must be sold only in stationary pharmacies operated by a person holding a pharmaceutical licence.
Russian Federation
13 Aug 2019
2
Approval Of Amendments To The General Health Law Concerning Front Labeling Of Food And Non-Alcoholic Beverages
On July 24, 2019, the Health Commission of the Chamber of Deputies approved the draft opinion that amends and adds various provisions to the General Health Law concerning overweight
Mexico
2 Aug 2019
3
Medical Foods Workshop: Science, Regulation And Practical Aspects
Xin Tao will serve as a panelist during the "Concepts around Differentiating Medical Foods and FSDU" session on 14 August.
United States
1 Aug 2019
4
Senate Finance Committee Releases Details Of Drug Pricing Bill
If enacted into law, the bill would have wide-ranging implications and would directly affect, among other stakeholders, drug manufacturers, insurers, hospitals, and physicians.
United States
1 Aug 2019
5
View From The Horizon: Pricing And Financial Regulation Of Health Products In France
On June 27 the third edition of our new global series, Life Sciences and Health Care Horizons, took place in Paris with discussions focused on the pricing and financial regulation of health products
France
31 Jul 2019
6
CMS Radiation Oncology Model Proposed Rule – Summary And Early Insights
Last week, the Centers for Medicare & Medicaid Services (CMS) announced new details of a proposed bundled payment model for radiation oncology services.
United States
25 Jul 2019
7
CDRH Issues Final Rule On Appeals, Excluding De Novos From 517A
On 2 July 2019 the U.S. Food and Drug Administration (FDA or the agency) issued a final rule1 updating the processes for appeal of certain FDA decisions related to medical devices regulated
United States
18 Jul 2019
8
MDRP And The U.S. Territories: Manufacturer Rebate Obligations, But No Mandatory Coverage, In Case Of A Section 1115 Waiver?
In the ACA Final Rule, the Centers for Medicare & Medicaid Service (CMS) expanded the definition of the terms "States" and "United States.
United States
18 Jul 2019
9
Fuelling Healthcare Innovation: Poland Creates New Medical Research Agency
In March 2019, the new law creating a Medical Research Agency ("the Agency") entered into force in Poland. This new entity is intended to play a similar role to institutions like the UK's Medical
Poland
12 Jul 2019
10
Balancing Safety And Efficiency: Updating The Regulation On Pharmaceuticals And Medical Devices
It's been five years since both the name and the content of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (the "Act")
Japan
12 Jul 2019
11
Mobile Phones And Exposure To EMF: Stay Tuned For More Information, Soon
In a decision handed down on 15 January 2019, the Regional Administrative Court of Lazio ("TAR Lazio") ordered the Ministry of Environment, the Ministry of Health and the Ministry of Education,
Italy
11 Jul 2019
12
Settlement Reached In Lawsuit To Compel FDA To Implement FSMA Traceability Provisions
The U.S. Food and Drug Administration (FDA) reached a settlement with the two consumer groups that sued FDA in October 2018 to compel the agency to implement the traceability provisions in the
United States
5 Jul 2019
13
View From The Horizon: Artificial Intelligence And Cannabusiness In London
On May 16 the second edition of our new global series, Life Sciences and Health Care Horizons, took place in London featuring two panel discussions that focused on the challenges
UK
27 Jun 2019
14
U.S. Supreme Court Ruling Expands Scope Of Medicare Notice-And-Comment Requirement
On 3 June 2019 the U.S. Supreme Court held in Azar v. Allina Health Services that Medicare interpretive guidance must go through notice-and-comment if it establishes or changes a substantive
United States
24 Jun 2019
15
Benchmark Pricing
In recent weeks, several leading pharmaceutical companies have been accused of conspiring to inflate the pricing of their products, some of which are used in the treatment of illnesses such as high cholesterol and HIV.
South Africa
24 Jun 2019
16
HHS Announces Public Meeting On Ways To Accelerate Clinical Innovation
The U.S. Department of Health and Human Services' (HHS) Immediate Office of the Secretary (IOS) has announced it will hold a public meeting June 20-21 to seek public input
United States
19 Jun 2019
17
Our Presence In The Middle East
Business across the Middle East continues to diversify and become more sophisticated. With declining oil prices and increasing international competition, CEOs are seeking new ways of doing business.
United Arab Emirates
11 Jun 2019
18
View From The Horizon: Digital Health And Cell, Tissue, And Gene Therapies In Boston
On April 30 our new global series, Life Sciences and Health Care Horizons, kicked off in Boston with two panel discussions that focused on the challenges ...
United States
7 Jun 2019
19
Survival Of The Fittest Or Cheapest?
T he past year is set to be a milestone year for China's pharmaceutical regulatory reform as the newly formed National Medical Products Administration (NMPA) continues to aggressively cut back on red
China
4 Jun 2019
20
CMS Proposes Long-Awaited Draft Guidance On Co-Located Hospitals
On May 3, 2019, the Centers for Medicare & Medicaid Services (CMS) issued draft manual guidance for surveyors evaluating whether hospitals ...
United States
3 Jun 2019
Links to Result pages
 
1 2 3  
>>Next